EIP
EW icon

Epoch Investment Partners’s Edwards Lifesciences EW Stock Holding History

Epoch Investment Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6M Sell
194,907
-7,799
-4% -$653K 0.1% 187
2026
Q1 		$16.2M Sell
202,706
-18,078
-8% -$1.49M 0.1% 193
2025
Q4 		$18.8M Sell
220,784
-26,179
-11% -$2.15M 0.11% 183
2025
Q3 		$19.2M Sell
246,963
-14,534
-6% -$1.14M 0.11% 180
2025
Q2 		$20.5M Sell
261,497
-89,476
-25% -$6.67M 0.11% 182
2025
Q1 		$25.4M Buy
350,973
+46,772
+15% +$3.35M 0.13% 178
2024
Q4 		$22.5M Sell
304,201
-29,294
-9% -$2.05M 0.11% 180
2024
Q3 		$22M Sell
333,495
-115,456
-26% -$8.39M 0.1% 188
2024
Q2 		$41.5M Buy
448,951
+914
+0.2% +$80.9K 0.19% 174
2024
Q1 		$42.8M Sell
448,037
-141,033
-24% -$11.8M 0.19% 182
2023
Q4 		$44.9M Buy
589,070
+266,292
+83% +$18.5M 0.2% 174
2023
Q3 		$22.4M Sell
322,778
-9,251
-3% -$743K 0.14% 189
2023
Q2 		$31.3M Sell
332,029
-4,607
-1% -$400K 0.18% 175
2023
Q1 		$27.8M Sell
336,636
-6,941
-2% -$546K 0.17% 180
2022
Q4 		$25.6M Buy
343,577
+257,972
+301% +$19.9M 0.15% 183
2022
Q3 		$7.07M Buy
85,605
+1,962
+2% +$189K 0.05% 284
2022
Q2 		$7.95M Buy
83,643
+2,664
+3% +$276K 0.05% 281
2022
Q1 		$9.53M Hold
80,979
– – 0.05% 283
2021
Q4 		$10.5M Sell
80,979
-14,176
-15% -$1.65M 0.05% 272
2021
Q3 		$10.8M Sell
95,155
-3
-0% -$342 0.06% 256
2021
Q2 		$9.86M Sell
95,158
-15,343
-14% -$1.45M 0.05% 258
2021
Q1 		$9.24M Buy
110,501
+26,364
+31% +$2.23M 0.04% 253
2020
Q4 		$7.68M Buy
84,137
+4,413
+6% +$366K 0.04% 252
2020
Q3 		$6.36M Buy
+79,724
New +$6.22M 0.03% 240

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Epoch Investment Partners's EW Position: Q2 2026 in Review

Epoch Investment Partners reduced its Edwards Lifesciences (EW) stake by 3.8% in Q2 2026, selling an estimated $653K and leaving 194,907 shares worth $17.6M. The position accounts for 0.1% of the portfolio, ranked #187.

Epoch Investment Partners first reported a position in EW in Q3 2020 and has held it in 24 quarters since. The position peaked at $44.9M in Q4 2023. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Epoch Investment Partners held 194,907 shares of Edwards Lifesciences worth $17.6M as of Q2 2026.
  • Epoch Investment Partners sold 7,799 Edwards Lifesciences shares in Q2 2026, an estimated $653K.
  • Edwards Lifesciences made up 0.1% of Epoch Investment Partners's portfolio in Q2 2026, its #187 holding.
  • Epoch Investment Partners first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 24 quarters since.
  • Epoch Investment Partners's Edwards Lifesciences position peaked at $44.9M in Q4 2023.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Epoch Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.